Metabolic Weekly — Evidence-Based Health Reporting

Evidence-based · Medically reviewed · Independent

Featured

Medicare Now Covers GLP-1 Weight Loss Drugs — Here's Exactly How to Get Coverage (Updated July 2026)

The Medicare GLP-1 Bridge Program, extended through December 2027, provides weight-loss GLP-1 coverage to millions of Part D beneficiaries who were previously excluded. Here is who qualifies, what is covered, and how to navigate prior authorization.

Renata Solis · Apr 27, 2026 · 7 min read

Medications

Best GLP-1 Providers of 2026: Ranked and Reviewed

Maren Thiessen · Feb 28, 2026

Medications

Compounded Semaglutide: What You Need to Know Before Buying Online

Brock Halverson · Mar 2, 2026

Weight Loss

How Much Does Semaglutide Actually Cost in 2026?

Renata Solís · Mar 2, 2026

Latest Coverage

GLP-1 News

FDA's April 2026 GLP-1 Compounding Update: What It Means for Your Prescription

On April 1, 2026, the FDA issued its most significant clarification yet on compounded GLP-1 drugs. With supply stabilizing and enforcement tightening, patients accessing semaglutide through telehealth need to understand what's changing. Here's what the policy actually says—and what it means for your treatment.

Brock Halverson · Apr 9, 2026

Conditions

GLP-1 Drugs Offer Unexpected Relief for Arthritis Pain, Patients Report

Emerging reports from patients using GLP-1 medications for weight management are revealing a surprising side effect: significant reductions in arthritis pain. While these drugs are primarily known for their efficacy in treating type 2 diabetes and obesity, a growing number of individuals are experiencing dramatic improvements in joint discomfort, particularly those suffering from osteoarthritis. This unexpected benefit is sparking new interest in the anti-inflammatory potential of GLP-1 agonists, prompting researchers to investigate the underlying mechanisms and clinical implications for millions seeking relief from chronic pain.

Brock Halverson · Mar 26, 2026

Nutrition

GLP-1 & Rapid Weight Loss: Safeguarding Your Electrolyte Balance

The transformative power of GLP-1 receptor agonists in obesity management is undeniable, leading to significant and often rapid weight loss. However, this accelerated metabolic shift can pose unique challenges, particularly concerning electrolyte balance. Understanding the critical minerals like sodium, potassium, and magnesium, and how to monitor their levels, is paramount for GLP-1 patients to ensure sustained health and prevent complications. This article delves into the essential strategies for maintaining optimal electrolyte health while on your weight loss journey.

Renata Solís · Mar 26, 2026

Research

Unlocking GLP-1 Variability: Why Weight Loss Differs So Wildly

GLP-1 receptor agonists have revolutionized weight management, offering unprecedented results for many, yet a significant proportion of patients experience only modest benefit. While some individuals achieve remarkable 25% body weight reductions, others see just 5% loss, prompting crucial research into this variability and the factors at play. This article explores the complex interplay of genetic predispositions, metabolic profiles, and lifestyle factors that dictate these divergent outcomes, providing essential insights for optimizing GLP-1 therapy and understanding personalized responses to achieve your weight loss goals.

Priya Mehra · Mar 26, 2026

Research

The Surprising Link: Autophagy, Fasting, and GLP-1s for Weight Loss

Globally, obesity rates are soaring, prompting a critical search for effective weight management strategies beyond traditional diets. This article delves into the fascinating intersection of autophagy, the body's cellular recycling process, and its profound role in weight loss, exploring how both intermittent fasting and revolutionary GLP-1 medications like Ozempic and Wegovy leverage remarkably similar biological pathways to promote metabolic health. Discover the shared mechanisms behind these powerful, modern approaches and how understanding their common ground can offer new, sustainable perspectives on combating the global obesity crisis.

Priya Mehra · Mar 26, 2026

GLP-1 News

Compounding Pharmacy Risks: How to Verify Your GLP-1 Source

The unprecedented demand for GLP-1 medications has fueled a rapid expansion in compounding pharmacies, creating a complex landscape where product quality and patient safety are paramount concerns. While compounded drugs can offer vital access to treatments, the absence of federal oversight means consumers face significant risks, from inconsistent dosages to contaminated ingredients. This article critically examines the inherent dangers associated with unregulated compounded medications and equips you with actionable strategies to thoroughly vet your pharmacy, ensuring the integrity and efficacy of your GLP-1 source and safeguarding your health.

Brock Halverson · Mar 26, 2026

From Our Editors

Renata Solis

Senior Health Reporter

"The GLP-1 market is evolving faster than regulations can keep up. Our job is to cut through the noise."

Maren Thiessen

Health & Wellness Editor

"Every ranking we publish is backed by weeks of research and real patient data -- not sponsored placements."